Friday, July 10, 2026

pharma · Eczema · GERD (Heartburn, Regurgitation, and Dyspepsia) Frequency

Hong Kong Baptist

Hong Kong Baptist clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
18
Drugs
14
Patents
0
Intelligence · Clinical Programs

Hong Kong Baptist projects

4 ClinicalTrials.gov programs sponsored by Hong Kong Baptist.

Hong Kong Baptist has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. CKD-371

    Hong Kong Baptist University

    Type II Diabetes Mellitus

    phase 1 small molecule completed

    1 trial
  2. CKD-381

    Hong Kong Baptist University

    GERD

    phase 1 small molecule completed

    1 trial
  3. CKD-393 formulation I

    Hong Kong Baptist University

    Type II Diabetes

    phase 1 small molecule completed

    1 trial
  4. CKD-581

    Hong Kong Baptist University

    Myeloma, Multiple

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Hong Kong Baptist have?

4 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.